NeOnc Technologies Holdings is trading 6.3% up at $3.54 after rising from the September 21 close of $3.33. Searches found no fresh September 22 company announcement directly explaining the pre-market move.
- Positive NEO100 Phase 2a results and approximately $629,000 in executive open-market purchases provided recent support; both disclosures date to September 16.
- The move may reflect continued interest in the biotechnology stock; modest current index gains do not establish a broader-market catalyst.